BMC cancer, 2024-01, Vol.24 (1), p.4-4, Article 4
2024
Details
- Autor(en) / Beteiligte
- Titel
- The emerging roles of long non-coding RNA (lncRNA) H19 in gynecologic cancers
- Ist Teil von
- BMC cancer, 2024-01, Vol.24 (1), p.4-4, Article 4
- Ort / Verlag
- England: BioMed Central Ltd
- Erscheinungsjahr
- 2024
- Link zum Volltext
- Quelle
- Free E-Journal (出版社公開部分のみ）
- Beschreibungen/Notizen
- Long non-coding RNA (lncRNA) H19 has gained significant recognition as a pivotal contributor to the initiation and advancement of gynecologic cancers, encompassing ovarian, endometrial, cervical, and breast cancers. H19 exhibits a complex array of mechanisms, demonstrating dualistic effects on tumorigenesis as it can function as both an oncogene and a tumor suppressor, contingent upon the specific context and type of cancer being investigated. In ovarian cancer, H19 promotes tumor growth, metastasis, and chemoresistance through modulation of key signaling pathways and interaction with microRNAs. Conversely, in endometrial cancer, H19 acts as a tumor suppressor by inhibiting proliferation, inducing apoptosis, and regulating epithelial-mesenchymal transition. Additionally, H19 has been implicated in cervical and breast cancers, where it influences cell proliferation, invasion, and immune evasion. Moreover, H19 has potential as a diagnostic and prognostic biomarker for gynecologic cancers, with its expression levels correlating with clinical parameters and patient outcomes. Understanding the functional roles of H19 in gynecologic cancers is crucial for the development of targeted therapeutic strategies and personalized treatment approaches. Further investigation into the intricate molecular mechanisms underlying H19's involvement in gynecologic malignancies is warranted to fully unravel its therapeutic potential and clinical implications. This review aims to elucidate the functional roles of H19 in various gynecologic malignancies.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1471-2407eISSN: 1471-2407DOI: 10.1186/s12885-023-11743-zTitel-ID: cdi_doaj_primary_oai_doaj_org_article_73ba8c894bbd4639aad2f22395a45f99
- Format
- –
- Schlagworte
- Analysis, Apoptosis, Biological markers, Biomarker, Biopsy, Breast cancer, Breast Neoplasms - genetics, Cancer, Cancer therapies, Carcinogenesis, Care and treatment, Cell growth, Cell Line, Tumor, Cell proliferation, Cell Proliferation - genetics, Cervical cancer, Chemoresistance, Chemotherapy, Dental pulp, Development and progression, Diagnosis, DNA methylation, Drug resistance, Endometrial cancer, Endometrium, Female, Fulvestrant, Gene Expression Regulation, Neoplastic, Genes, Genetic aspects, Genital cancer, Genital Neoplasms, Female - genetics, Genomes, Gynecologic cancer, H19, Health aspects, Human papillomavirus, Humans, Kinases, Laparoscopy, LncRNAs, Malignancy, Metastases, Metastasis, MicroRNAs, MicroRNAs - genetics, MicroRNAs - metabolism, miRNA, Molecular modelling, Non-coding RNA, Ovarian cancer, Prevention, Radiation therapy, Review, Risk factors, RNA, RNA, Long Noncoding - genetics, RNA, Long Noncoding - metabolism, Signal Transduction, Stem cells, Tomography, Tumor suppressor genes, Tumorigenesis, Tumors, Uterine cancer